Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 30 most recent Form 4 transactions.
| Jun 11 | DARE | Dare Bioscience, Inc. | AGRANT◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 2,567 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 3,318 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER | 3,318 | — | — | +8.2% | Open the original filing on SEC.gov |
| May 5 | FATE | Fate Therapeutics INC | MEXER◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 5 | FATE | Fate Therapeutics INC | MEXER | 25,000 | $1.69 | $42.3K | +220.6% | Open the original filing on SEC.gov |
| Nov 5, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 18,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 5, 2025 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 18,000 | $151.82 | $2.7M | -30.8% | Open the original filing on SEC.gov |
| Nov 5, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 18,000 | $47.89 | $862K | +44.6% | Open the original filing on SEC.gov |
| Jul 9, 2025 | DARE | Dare Bioscience, Inc. | AGRANT◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 2,325 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS◆ | 4,650 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | DTOISS | 57,292 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 25, 2025 | RGLS | Regulus Therapeutics Inc. | UTENDR | 44,264 | — | — | -43.6% | Open the original filing on SEC.gov |
| May 29, 2025 | FATE | Fate Therapeutics INC | AGRANT◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,869 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | NBIX | Neurocrine Biosciences INC | MEXER | 2,869 | — | — | +7.6% | Open the original filing on SEC.gov |
| May 21, 2025 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 3,318 | — | — | — | Open the original filing on SEC.gov |
| May 5, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| May 5, 2025 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 30,000 | $110.20 | $3.3M | -44.5% | Open the original filing on SEC.gov |
| May 5, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 30,000 | $42.76 | $1.3M | +80.0% | Open the original filing on SEC.gov |
| Apr 30, 2025 | RGLS | Regulus Therapeutics Inc. | AGRANT | 62,500 | — | — | +160.0% | Open the original filing on SEC.gov |